|
Volumn 3, Issue 3, 1999, Pages
|
Hormonal sex reassignment
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANTIANDROGEN;
CYPROTERONE ACETATE;
ESTROGEN;
ETHINYLESTRADIOL;
FINASTERIDE;
FLUTAMIDE;
GONADORELIN AGONIST;
MEDROXYPROGESTERONE ACETATE;
NILUTAMIDE;
PROLACTIN;
SEX HORMONE;
SPIRONOLACTONE;
TESTOSTERONE ESTER;
ACNE;
BREAST CANCER;
CANCER INCIDENCE;
CANCER SUSCEPTIBILITY;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR DISEASE;
DECISION MAKING;
DIABETES CONTROL;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MEGADOSE;
ELECTIVE SURGERY;
FAMILY HISTORY;
GENDER DYSPHORIA;
HAIR;
HORMONAL THERAPY;
HUMAN;
LIVER DISEASE;
MEDICOLEGAL ASPECT;
MENSTRUATION;
OBESITY;
PROLACTIN RELEASE;
PROSTATE CARCINOMA;
PUBERTY;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SEXUAL DEVELOPMENT;
THROMBOEMBOLISM;
TRANSSEXUALISM;
TREATMENT CONTRAINDICATION;
VEIN THROMBOSIS;
|
EID: 4344711374
PISSN: 14344599
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (19)
|
References (7)
|